V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019670 | 270010126 | 1.78 | null | Palliative (P) | 2014-12-01 | 2014-12-02 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270018171 | VEPEMB |
| 270019671 | 270010139 | 1.72 | null | Palliative (P) | 2017-11-23 | 2018-01-09 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | null | N | 270018255 | OXALIPLATIN + RALTITREXED |
| 270019672 | 270014738 | 1.75 | 58.6 | Curative (C) | 2018-03-25 | 2018-04-01 | Panitumumab | 02 | N | 270018269 | CARBOPLATIN |
| 270019673 | 270010146 | null | 56.8 | Palliative (P) | 2016-03-23 | 2016-03-25 | NIVOLUMAB | N | N | 270018302 | NIVOLUMAB |
| 270019674 | 270010155 | 1.76 | 75 | Curative (C) | 2017-05-01 | 2017-05-09 | FEC 100 | N | Y | 270018394 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270019675 | 270010156 | 1.65 | 64.9 | Palliative (P) | 2017-12-17 | 2017-12-30 | IBRUTINIB | 02 | N | 270018427 | FOXTROT TRIAL |
| 270019676 | 270010162 | 1.65 | null | Curative (C) | 2017-07-10 | 2017-08-09 | Bevacizumab+Irinotecan+Raltitrexed | 02 | Y | 270018453 | CETUXIMAB + MDG |
| 270019677 | 270010167 | 1.64 | 57.2 | Curative (C) | 2014-10-10 | 2014-12-19 | IVADo | 02 | N | 270018473 | CAPECITABINE + OXALIPLATIN + MDG |
| 270019678 | 270014751 | 1.62 | 75 | Curative (C) | 2015-08-26 | 2015-08-26 | CARBOPLATIN + RT | 2 | N | 270018521 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270019679 | 270010192 | null | 67 | Palliative (P) | 2018-06-10 | 2018-06-11 | Docetaxel | 02 | N | 270018776 | CYCLOPHOSPHAMIDE |
| 270019680 | 270010202 | 1.69 | 50 | Palliative (P) | 2018-07-24 | 2018-08-01 | R GCVP | 02 | Y | 270018827 | BLEOMYCIN |
| 270019681 | 270010204 | 1.68 | 89.7 | Disease modification (D) | 2014-01-01 | 2014-01-09 | ICE (no GCSF) | N | N | 270018829 | RATHL TRIAL |
| 270019682 | 270010208 | 1.65 | 64.35 | Palliative (P) | 2017-11-05 | 2017-11-05 | Chlorambucil + Pred + Vinblastine | Y | N | 270018834 | GEMCITABINE + VINORELBINE |
| 270019683 | 270010219 | 1.75 | 87.1 | null | 2016-10-16 | 2017-06-11 | Y-90 | 2 | N | 270018889 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 270019684 | 270014776 | 1.64 | 51.4 | Palliative (P) | 2019-06-11 | 2019-06-11 | Etoposide IV | N | N | 270018894 | RCEOP |
| 270019685 | 270010250 | 1.94 | 84.8 | Curative (C) | 2014-08-11 | 2014-08-11 | CLADRIBINE | 02 | N | 270019375 | RATHL TRIAL |
| 270019686 | 270014794 | 1.58 | 60 | null | 2015-03-14 | 2015-03-14 | VINCRISTINE | 2 | N | 270019599 | CYCLOPHOSPHAMIDE |
| 270019687 | 270010273 | 1.77 | 80 | Palliative (P) | 2014-09-25 | 2015-01-08 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE | N | N | 270019601 | ICE |
| 270019688 | 270014801 | 1.64 | 50.6 | Palliative (P) | 2017-06-27 | 2017-09-20 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 02 | N | 270019721 | Y-90 |
| 270019689 | 270010300 | 1.77 | 92.2 | Palliative (P) | 2015-06-27 | 2019-02-27 | Chlorambucil | Y | N | 270019883 | CYCLOPHOSPHAMIDE |
| 270019690 | 270010311 | 1.68 | 66.3 | Disease modification (D) | 2014-06-22 | 2014-09-15 | ICE (no GCSF) | N | N | 270019944 | CVP R |
| 270019691 | 270010316 | 1.64 | 75.2 | Curative (C) | null | 2013-11-05 | ECHELON 1 TRIAL | N | N | 270019972 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 270019692 | 270010322 | null | 57.9 | Curative (C) | 2018-04-29 | 2018-04-29 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 270019995 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270019693 | 270010327 | 1.6 | 63 | Curative (C) | 2014-05-14 | 2014-05-15 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 02 | N | 270019996 | NHL 2003 |
| 270019694 | 270014844 | 1.77 | 81.7 | Curative (C) | 2017-07-19 | 2018-05-12 | Ifosfamide | 02 | Y | 270020545 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN |
| 270019695 | 270010383 | 1.83 | 84.6 | Palliative (P) | null | 2016-04-08 | CLADRIBINE | 2 | Y | 270020661 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270019696 | 270010386 | 1.87 | null | Curative (C) | 2018-10-20 | 2018-11-01 | ECHELON 1 TRIAL | 2 | N | 270020719 | METHOTREXATE INTRATHECAL |
| 270019697 | 270010390 | 1.68 | 84.6 | Not known (9) | 2019-01-20 | 2019-02-15 | LENALIDOMIDE | N | N | 270020741 | BORTEZOMIB |
| 270019698 | 270014854 | 1.58 | 82.4 | Curative (C) | 2014-02-22 | 2014-07-19 | MELPHALAN | N | N | 270020762 | METHOTREXATE INTRATHECAL |
| 270019699 | 270014861 | 1.62 | 79 | Disease modification (D) | 2018-09-12 | 2018-10-28 | Nilotinib | N | N | 270021045 | ETOPOSIDE |
| 270019700 | 270010433 | 1.65 | 66.1 | Disease modification (D) | 2019-10-17 | 2019-12-17 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 270021516 | CYCLOPHOSPHAMIDE |
| 270019701 | 270010444 | 1.75 | 80 | Curative (C) | 2017-03-03 | 2017-03-31 | AFATINIB | N | N | 270021829 | CAV |
| 270019702 | 270010467 | 1.45 | 57.9 | Adjuvant (A) | 2018-12-03 | 2018-12-10 | ECHELON 1 TRIAL | N | N | 270022215 | RATHL TRIAL |
| 270019703 | 270010476 | 1.56 | 58 | Adjuvant (A) | 2014-11-03 | 2014-11-13 | CARBOPLATIN + GEMCITABINE | N | N | 270022283 | CARBOPLATIN + CETUXIMAB + FU |
| 270019704 | 270010517 | 1.8 | null | Adjuvant (A) | 2018-10-03 | 2018-10-11 | IDELALISIB + RITUXIMAB | N | null | 270022895 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 270019705 | 270010525 | 1.54 | 50.8 | Palliative (P) | 2015-08-19 | 2015-08-20 | GEMCITABINE + VINORELBINE | N | N | 270022984 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270019706 | 270018539 | 1.94 | 73.3 | Palliative (P) | 2017-12-30 | 2017-12-30 | MELPHALAN | N | N | 270022987 | BENDAMUSTINE + BRENTUXIMAB |
| 270019708 | 270010541 | null | 55.2 | Palliative (P) | 2017-11-18 | 2018-10-26 | ECHELON 1 TRIAL | N | N | 270023166 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 270019709 | 270010562 | 1.75 | null | Curative (C) | 2016-10-12 | 2016-10-28 | Hydroxycarbamide | null | null | 270023353 | RATHL TRIAL |
| 270019710 | 270010569 | 1.84 | 58.2 | Curative (C) | 2016-01-10 | 2016-01-10 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 270023443 | CARBOPLATIN + RT |
| 270019711 | 270010574 | 1.7 | 58.1 | Curative (C) | 2018-06-08 | 2018-06-20 | Bevacizumab + CAPECITABINE + IRINOTECAN | N | null | 270023459 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270019712 | 270010593 | 1.71 | 78.4 | Curative (C) | null | 2018-03-09 | OXALIPLATIN | null | null | 270023690 | CARBOPLATIN + RT |
| 270019713 | 270010631 | 1.6 | 80 | Neo-adjuvant (N) | 2017-10-18 | 2017-10-19 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 270024270 | IRINOTECAN + MDG + PANITUMUMAB |
| 270019714 | 270010671 | null | 76 | Adjuvant (A) | 2019-04-26 | 2019-05-02 | Raltitrexed | 2 | N | 270024790 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270019715 | 270014985 | null | 71 | Disease modification (D) | 2019-12-31 | 2020-01-04 | GemCarbo Days 1+8 | null | N | 270024883 | IRINOTECAN + RALTITREXED |
| 270019716 | 270010695 | 1.58 | 66 | Neo-adjuvant (N) | 2017-05-11 | 2017-05-12 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 02 | N | 270025108 | GEMCITABINE + OXALIPLATIN |
| 270019717 | 270018562 | 1.67 | 48.7 | Palliative (P) | 2017-08-21 | 2017-09-01 | Carbo F | N | N | 270025137 | ABIRATERONE |
| 270019718 | 270010702 | 1.76 | 84.6 | Palliative (P) | 2018-04-14 | 2018-04-14 | CARBO + FLUOROURACIL | 02 | N | 270025142 | CARBO + FLUOROURACIL |
| 270019719 | 270010735 | 1.67 | 65 | Disease modification (D) | 2018-04-06 | 2018-05-23 | CARBOPLATIN + RT | 2 | N | 270025878 | DA |
| 270019720 | 270015017 | 1.85 | 124.3 | Curative (C) | 2019-07-28 | 2019-07-28 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 270002435 | CAPECITABINE + CETUXIMAB |